Short course corticosteroid treatment and closed-loop insulin delivery system: The experience of the DBLG1 pre-launch

Diabetes Metab. 2022 Jul;48(4):101294. doi: 10.1016/j.diabet.2021.101294. Epub 2021 Oct 16.

¹ Department of Diabetes and Endocrinologyt, Sud-Francilien Hospital, Paris-Saclay University, Corbeil-Essonnes, France; Paris-Saclay University, France. Electronic address: coralie.amadou@u-psud.fr.
² Department of Diabetes and Endocrinologyt, Sud-Francilien Hospital, Paris-Saclay University, Corbeil-Essonnes, France; CERITD (Center for Study and Research for the Intensification of Diabetes Treatment), Bioparc-Génopole, Évry, France; LBEPS, Univ Evry, IRBA, Université Paris Saclay, Evry 91025, France.
³ Diabeloop SA.
⁴ Department of Diabetes and Endocrinologyt, Sud-Francilien Hospital, Paris-Saclay University, Corbeil-Essonnes, France; CERITD (Center for Study and Research for the Intensification of Diabetes Treatment), Bioparc-Génopole, Évry, France.
⁵ Department of Diabetes and Endocrinologyt, Sud-Francilien Hospital, Paris-Saclay University, Corbeil-Essonnes, France; Paris-Saclay University, France.

Abstract

No abstract (brief report).

Keywords: Closed-loop system; Corticosteroid; Type 1 diabetes.